Fig. 2.

Anti-angiogenic agents can increase radiation sensitivity—the use of antiangiogenic agents can normalize tumor vasculature which increases tumor perfusion while decreasing interstitial pressure. The increased oxygen content in the formerly hypoxic tumor gives rise to elevated reactive oxygen species (ROS) upon irradiation, leading to increased DNA damage, mitotic catastrophe, and ultimately, cell death.